Aldeyra Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Aldeyra Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Aldeyra Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $105M, a 10.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $105M +$10.2M +10.8% Dec 31, 2023 10-K 2024-03-07
Q4 2022 $94.6M +$17.8M +23.2% Dec 31, 2022 10-K 2024-03-07
Q4 2021 $76.8M +$18.1M +30.9% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $58.7M +$8.55M +17% Dec 31, 2020 10-K 2022-03-17
Q4 2019 $50.2M +$15.8M +46% Dec 31, 2019 10-K 2021-03-11
Q4 2018 $34.4M +$12.2M +55.4% Dec 31, 2018 10-K 2020-03-12
Q4 2017 $22.1M +$337K +1.55% Dec 31, 2017 10-K 2019-03-08
Q4 2016 $21.8M +$7.37M +51.1% Dec 31, 2016 10-K 2018-03-29
Q4 2015 $14.4M +$4.84M +50.6% Dec 31, 2015 10-K 2017-03-30
Q4 2014 $9.57M +$16.4M Dec 31, 2014 10-K 2016-03-30
Q4 2013 -$6.79M Dec 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.